Posted Nov. 22, 2011 at 11:39 a.m.
Furiex
Research Triangle Park, N.C. — Regulars push back a decision about a type 2 diabetes drug that a Japanese firm has licensed from Furiex. Copyright 2013 MedCity. All rights reserved.
FDA delay means no $25M payment for Furiex - yet
Post a comment
Print this blog postE-mail blog post
Share
Furiex
Research Triangle Park, N.C. — Regulars push back a decision about a type 2 diabetes drug that a Japanese firm has licensed from Furiex. Copyright 2013 MedCity. All rights reserved.
Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Durham's high-tech infrastructure, talent lure Virginia company- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows
- Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
- Triangle politician tries to accelerate crowdfunding; bill passes first hurdle